bioRxiv
A single-domain antibody targets aggregation-prone region of α-synuclein to reduce synucleinopathy, rescue neurodegeneration and improve function
Preprint: experiments in model organismsInterventions
The paper
New York University
bioRxiv, 10 Jul 2026, Preprint, not peer-reviewed
